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Identity 
Other names: HSP27; HSP28; Hsp25; CMT2F; 
HMN2B; SRP27; HS.76067; DKFZp586P1322 
HGNC (Hugo): HSPB1 
Location: 7q11.23 
Local order: Genes flanking HSPB1 in centromere to 
telomere direction: 
- MDH2 (mitochondrial malate dehydrogenase 
precursor) 
- FLJ37078 (hypothetical protein LOC222183) 
- HSPB1 
- YWHAG (tyrosine 3-monooxygenase/tryptophan) 
- SRCRB40 (scavenger receptor cysteine-rich domain-
containing group B protein precursor) 
DNA/RNA 
Description 
The DNA sequence (1.69 Kb) contains 3 exons. 
Transcription 
The transcript is 847 bp. 
Pseudogene 
Two pseudogenes have been identified: 
- a processed retropseudogene lacking promoter 
elements on Xp11.23 (Hickey et al., 1996); 
- a 5'-truncated semiprocessed retropseudogene on 
9q13-9q21 (Kappe et al., 2003). 
Protein 
Note 
HspB1 belongs to the ubiquitous family of small heat 
shock proteins (sHsps). sHsps are characteri-zed by low 
molecular mass (12-30 kDa), a conserved C-terminal 
"a-crystallin" domain and oligomeric structure. sHsps 
bind denatured proteins and facilitate their refolding by 
the ATP-dependent molecular chaperones of the Hsp70 
family (Haslbeck et al., 2005; Sun and MacRae, 2005). 
Description 
HspB1 is a protein of 205 amino acids (22783 Da), 
which can be phosphorylated at serines 15, 78 and 82 
by mitogen- activated protein kinases associated 
protein kinases (MAPKAP kinase 2, MAPKAP kinase 
3). Various signals modulate HspB1 phos-phorylation: 
growth factors, tumor necrosis factor, differentiating 
agents, heat and oxidative stress (Arrigo et al., 2007). 
HspB1 forms oligomers up to 1000 kDa, which are 
dynamic structures. Phospho-rylation results in a 
decrease size of the oligomers (Kato et al., 1994; 
Rogalla et al., 1999). Dissocia-tion of the oligomers is 
required for recognition of protein substrates 
(Shashidharamurthy et al., 2005). 
 
Fig.1. HspB1 contains an N-terminal hydrophobic domain with a WDFP motif and an alpha-crystallin domain at residues Glu87-Pro168. 
The arrows indicate phosphorylation sites at serines 15, 78 and 82. 
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It has been reported that HspB1 forms hetero-oligomers 
with other sHsps: alphaB-crystallin (HspB5) and Hsp20 
(HspB6) (Zantema et al., 1992; Sugiyama et al., 2000; 
Bukach et al., 2009). 
Expression 
Ubiquitous, produced constutively at high levels in 
heart and skeletal muscles (Sugiyama et al., 2000); 
overexpressed in response to a wide variety of 
physiological and environmental insults; produced at 
high levels in many tumors (Garrido et al., 2006). 
Increased expression of HspB1 in response to the 
aggregation of proteins specific for conformational 
diseases have been reported by several authors (Outeiro 
et al., 2006; Vleminckx et al., 2002). 
Localisation 
Cytosol, nucleus. HspB1 has been identified as a 
component of the nuclear speckles, structures implied 
in RNA processing (Bryantsev et al., 2007). 
HspB1 interacts with actin, intermediat filaments and 
microtubules (Landry and Huot, 1995; Mounier and 
Arrigo, 2002; Lee et al., 2005; Hino et al., 2000; Jonak 
et al., 2002). During ischemia in muscles, HspB1 is 
translocated from the cytosol to myofibryls 
(Golenhoffen et al., 2004). 
HspB1 accumulates in protein aggregates associated 
with conformational diseases: Parkinson's disease 
(Outeiro et al., 2006; Zourlidou et al., 2004), Alexander 
disease (Iwaki et al., 1993), Alzheimer's disease 
(Wilhelmus et al., 2006). 
HspB1 was also detected as a surface membrane 
protein in some cancer cell types (Shin et al., 2003). 
Function 
HspB1 acts as an ATP-independent molecular 
chaperone and prevents irreversible aggregation of 
bound substrates in vitro (Jakob et al., 1993). 
HspB1 is involved in the remodeling of cytoskeleton 
during embryogenesis and protection of the 
cytoskeleton in cells exposed to various stresses, 
particularly in the skeletal and cardiac muscles 
(Mounier and Arrigo, 2002; Sugiyama et al., 2000; 
Golenhofen et al., 2004; Salinthone et al., 2008). 
HspB1 phosphorylated by p38 MAP kinase is 
necessary for migration of vascular smooth muscle 
cells, neutrophils, fibroblasts and breast epithelial cells 
(Salinthone et al., 2008). 
HspB1 inhibits translation during heat shock by 
binding eIF4G and facilitating dissociation of cap-
initiation complexes (Cuesta et al., 2000). 
HspB1 interacts with different proteins of the 
programmed cell death machinery and thereby blocks 
apoptosis at distinct key points. It has been 
demonstrated that HspB1 sequesters cytochrome C and 
thus, prevents assembly of the apoptosome (Bruey et 
al., 2000a; Concannon et al., 2001). The release of 
Smac/Diablo from mitochondria is also blocked by 
HspB1 (Chauhan et al., 2003). In addition, HspB1 
inhibits activation of procaspase-3 by caspase 9 
(Garrido et al., 1999; Concannon et al., 2001). HspB1 
prevents translocation of pro-apoptotic Bid to 
mitochondria by stabilization of actin microfilaments 
(Paul et al., 2002). Havasi et al. (2008) demonstrated 
that HspB1 inhibits activation of pro-apoptotic Bax 
protein via a phosphatidylinositol 3-kinase-dependent 
mecha-nism. In the extrinsic pathway (receptor-
mediated cell death) HspB1 prevents interaction of 
DAXX (death domain associated protein) with Fas 
death receptor and protein kinase Ask1 in caspase-
independent pathway (Charette et al., 2000). It has been 
reported by Rane et al. (2003) that HspB1 controls 
apoptosis by binding cytoprotective protein kinase B 
(Akt). Anti-oxidant properties of HspB1 play an 
important function in the regulation of apoptosis. 
HspB1 maintain glutathione in its reduced form and 
decrease the amount of reactive oxygen species (ROS) 
produced in cells exposed to oxidative stress or tumor 
necrosis factor TNFalpha (Arrigo et al., 2007). HspB1 
may indirectly affect apoptosis by promoting 
degradation of death regulatory proteins by ubiquitn-
proteasome path-way. Under stress conditions HspB1 
stimulates ubiquitination of I-kappaBalpha, an inhibitor 
of the anti-apoptotic transcription factor NF-kappaB, 
and Kip1 a cyclin-dependent kinase inhibitor. The 
HspB1- mediated proteolysis of p27Kip1 facilitates 
progression from Go/G1 to S-phase of the cell cycle 
(Parcellier et al., 2006). 
In cancer cells HspB1 participates in oncogenesis and 
resistance to chemotherapy (see below). It has also 
been reported that expression of recombinant HspB1 at 
elevated levels leads to protection of human mammary 
epithelial cells from doxorubicin. The protection is
associated with suppression of the doxorubicin-induce  
senescence, where HspB1 inhibits p53-mediated 
induction of p21 (O'Callaghan-Sunol et al., 2007). 
However, Venkatakrishnan and co-workers (2008) 
demonstra-ted that HspB1 causes p21 upregulation and 
G2/M phase cell cycle arrest in doxorubicin-treated 
fibroblasts. 
Homology 
HspB1 shares homology trough the conserved alpha-
crystallin domain with other members of the sHsps 
family. Eleven human sHsps have been identified so 
far: HspB1 (Hsp27) HspB2, HspB3, alphaA-crystallin 
(HspB4), alphaB-crystallin (HspB5), Hsp20 (HspB6), 
cvHsp (HspB7), HspB8 (H11), HspB9, HspB10 




Mutations in the HSPB1 gene were found to cause 
distal hereditary motor neuropathy type II (dHMN II)
or Charcot-Marie-Tooth disease type 2F  
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Fig2. Distribution of HSPB1 mutations in dHMN II and CMT2F patients. 
dHMN: distal hereditary motor neuropathy, CMT: Charcot-Marie-Tooth type 2F disease, AD: autosomal dominant, AR: autosomal 
recessive. 
 
(CMT2F). Five of the mutations are located in the 
alpha-crystallin domain (see figure 2). 
Dierick and co-workers (2007) identified a HSPB1 
promoter variant (c.-217T>C) in an ALS patient, which 






Increased levels of HspB1 have been detected in breast 
cancer, ovarian cancer, osteosarcomas, endometrial 
cancer and leukemias (Garrido et al., 2006; Ciocca and 
Calderwood, 2005). It was also reported that the pattern 
of HspB1 phosphorylation in tumor cells is different 
from that observed in nontransformed cells (Sarto et al., 




Overexpression of HspB1 correlates with poor 
prognosis in gastric, liver, prostate carcinoma and 
osteosarcomas (Glaessgen et al., 2008; Romani et al., 
2007; Ciocca and Calderwood, 2005). 
Increased IbpB1 expression is associated with a  
favorable prognosis in schistosomiasis-associated 
bladder carcinoma (El-Meghawry El-Kenawy et al., 
2008), neuroblastoma (Zanini et al., 2007) and non-
small cell lung carcinoma (Malusecka et al., 2008). 
Patients with reduced HspB1 expression have poorer 
survival rates in oral squamous cell carcinoma (Lo 
Muzio et al., 2004) and ovarian carcinoma (Geisler et 
al., 2004). 
Lower lymphocyte HspB1 level is associated with an 
















HspB1 is involved in oncogenesis and resistance to 
various anti-cancer therapies due to its cytoprotectiv  
activities. It is suggested that HspB1 plays a crucial 
function during metastasis formation (Zhao et al., 
2007). 
Strategies combining chemo- or radiotherapy with 
down-regulation of HspB1 have been proposed as 
effective anti-cancer treatments. The HspB1  
knockdown by using small interfering RNA (siRNA) 
increases sensitivity of human epithelial cells to 
geldanamycin (McCollum et al., 2006) and pancreatic 
cancer cells to gemcitabine (Mori-Iwamoto et al., 
2007). Blocking HspB1 by antisense RNA restores 
apoptosis induced by drugs in multiple myeloma cells 
(Chauhan et al., 2003) and human bladder cancer cells 
(Kamada et al., 2007). Various cancer cells transfected 
with antisense Hsp27 cDNA exhibits increased 
sensitivity to gamma-irradiation (Aloy et al., 2008). 
Down regulation of HspB1 by interferon C enhances 
drug sensitivity in oral squamous cell carcinoma 
(Yonekura et al., 2003). Kim et al. (2007) has 
demonstrated that a heptapeptide derived from protein 
kinase C delta (PKC delta)-V5 region sequesters 
HspB1 and sensitizes human cancer cells to irradiation 
and cisplatine. 
Charcot-Marie-Tooth type IIF disease 
(CMT-IIF) / distal hereditary motor 
neuropathy (dHMN) 
Note 
A number of mutations in HspB1 has been identified 
that are associated with dHMNII or CMT2F (table of 
figure 2). The exact pathogenic mechanism of the 
HspB1 mutations is not yet understood. Expression of 
the mutant HspB1 (P182S) results in the formation of 
insoluble aggregates, affects assembly of neurofilament 
net-work and axonal transport in cortical neurons 
(Ackerley et al., 2006; Evgrafov et al., 2004; Zhai et 
al., 2007). 
Disease 
CMT disease and dHMN belong to a clinically 
heterogeneous group of disorders characterized by 
progressive weakness and distal limb muscle atrophy 
due to nerve degeneration. The neuropathy of CMT 
affects both motor and sensory nerves. The phenotype 
of dHMN II resembles CMT2F, but sensory 
abnormalities are absent in dHMNII. 
Conformational disorders 
Disease 
One of the characteristics of neurodegenerative 
diseases such as Alzheimer's disease (AD), Parkinson's 
disease (PD), amylotrophic lateral sclerosis (ALS) and 
Huntington disease is the formation of protein 
aggregates. HspB1 and other molecular chaperones are 
often detected as components of these aggregates. 
Cerebral deposits of intracellular neurofibrylllary 
tangles and extracellular aggregates of amyloid beta 
peptide (Abeta) are the pathological hallmarks of 
Alzheimer's disease. Intracellular Lewy bodies 
associated with Parkinson's disease contain alpha-
synuclein. In Huntington's disease (HD), a proteo-lytic 
fragment of the huntingtin protein that contains an 
expanded polyglutamine tract (polyQ), misfolds and 
forms aggregates. Rosenthal fibers of Alexander 
disease are cytoplasmic inclusions within astrocytes, 
which contain glial fibrillary acidic protein (GFAP) 
(Iwaki et al., 1993; Der Perng et al., 2006). 
Numerous studies indicate that molecular chaperones 
associated with intra- and extracellular protein deposits, 
affects their production and toxicity. 
It has been reported that HspB1 inhibits assembly of 
Abeta fibryls in vitro and reduces cerebrovascular 
toxicity of Abeta (Wilhelmus et al., 2006). HspB1 also 
inhibits GFAP polymerization (Der Perng et al., 2006) 
and toxicity induced by overexpression of alpha-
synuclein or polyQ in neuronal cells (Outeiro et al., 
2006; Zourlidou et al., 2004; Wyttenbach et al., 200 ). 
It is proposed that the sequestering of HspB1 by 
Rosenthal fibers diminishes its function as an anti-
apoptotic factor which in turn results in astrocytes 
degeneration (Mignot et al., 2004). Similarly, 
association of HspB1 with mutated Cu/Zn superoxide 
dismutase 1 (SOD1) may induce apoptosis (Okado-
Matsumoto and Fridovich, 2002). Missense mutations 
in the gene coding for SOD1 cause familial cases of 
amyotrophic lateral sclerosis (ALS) characterized by 
the death of large motor neurons in the cerebral cortex 
and spinal cord (Rakhit and Chakrabartty, 2006). 
Williams syndrome 
Note 
Stock et al. (2003) used FISH to map the HspB1 gene 
and they found that the band 7q11.23 also contains he 
site of the deletion associated with Williams sydrome 
(WS). The HSPB1 gene was deleted in three out of six 
WS patients examined in this study. 
Disease 
Williams syndrome (WS, also known as Williams- 
Beuren syndrome, WBS) is a rare neurodevelop-mental 
disorder characterized by multiple anoma-lies 
including: typical facial dysmorphisms (elfin face), 
congenital heart defects, infantile hypercalcemia, 
mental retardation and growth deficiency. 
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